The International Society on Thrombosis and Haemostasis (ISTH) has announced a new partnership with Elsevier, a global leader in information and analytics, to publish its two scientific publications, the Journal of Thrombosis and Haemostasis (JTH) and Research and Practice in Thrombosis and Haemostasis (RPTH). The journals will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2023.
As the flagship journal of the ISTH and celebrating its 20th anniversary in 2023, JTH continues to be a leading resource in the field publishing high-quality, original research reports, state-of-the-art reviews, brief reports, case reports, invited commentaries and more. Its authors, reviewers and editors volunteer their time and expertise to contribute and disseminate important scientific information to the international research community with a hybrid subscription-based model.
In 2022, the JTH achieved a historically high impact factor of 16.036, ranked fifth overall in the hematology subject category and ranked third in the peripheral vascular disease category.
RPTH, celebrating its fifth anniversary in 2022, is an exclusive open-access and online-only publication dedicated to science and discourse among researchers, clinicians, nurses, allied health professionals, as well as patients. RPTH serves as a catalyst for global discussion and connects scientists and clinicians with the non-scientist public to discuss the latest findings and research in the field. In 2021, the journal was accepted into the Science Citation Index Expanded (SCIE) qualifying it to receive its first Impact Factor of 5.953 this year. RPTH also ranked 24th overall in the hematology subject category and ranked 16th in the peripheral vascular disease category.
For more information on JTH and RPTH, visit https://www.isth.org/page/Publications.
Click here to read the original press release.
